This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MetLife (MET) Unit to Manage 3M's $2.5B Pension Obligations
by Zacks Equity Research
MetLife's (MET) unit, Metropolitan Tower Life, is set to take over around $2.5 billion in defined benefit pension obligations from 3M, ensuring continued monthly payments to nearly 23,000 retirees.
Brown & Brown (BRO) Rises 27% YTD: Can It Retain the Upside?
by Zacks Equity Research
Higher core commissions and fees, new business, solid retention, rate increases, strategic acquisitions, a strong financial position and effective capital deployment poise Brown & Brown (BRO) for growth.
Bet on These 4 Low-Beta Stocks to Navigate Market Uncertainty
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. The Vita Coco (COCO), Seanergy (SHIP), Arcos Dorados (ARCO) & Palomar (PLMR) are well-poised to gain.
Here's Why You Should Stay Invested in Kinsale (KNSL) Stock
by Zacks Equity Research
Kinsale (KNSL) appears well poised for growth on its focus on the excess and supply market, prudent underwriting, lower expense ratio, growth in the investment portfolio and effective capital deployment.
Here's Why You Should Add Palomar Holdings (PLMR) to Your Kitty
by Zacks Equity Research
Palomar Holdings (PLMR) is poised to gain from the expansion of its products' geographic and distribution footprint, new partnerships, higher average balance of investments and improved loss ratio.
Here's Why You Should Stay Invested in Travelers (TRV) Stock
by Zacks Equity Research
Strong renewal rate change, retention and increase in new business supported by a compelling portfolio and solid capital position poise Travelers (TRV) for growth.
Arch Capital (ACGL) Rises 35% YTD: Can It Retain the Upside?
by Zacks Equity Research
Arch Capital (ACGL) continues to gain from business opportunities, rate increases, growth in existing accounts and a solid capital position.
Why You Should Stay Invested in Cincinnati Financial (CINF)
by Zacks Equity Research
Higher level of insured exposure, rate increase, agent-focused business model, consistent cash flow and a solid capital position poise Cincinnati Financial (CINF) for growth.
Reasons Why You Should Add RLI Stock to Your Portfolio Now
by Zacks Equity Research
RLI stands to gain from a compelling product portfolio, rate increases, improved retention, higher premium receipts, sufficient liquidity and effective capital deployment.
Trupanion (TRUP) Rallies 27% in a Year: More Upside Left?
by Zacks Equity Research
Focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position continue to drive Trupanion (TRUP).
Are Finance Stocks Lagging Palomar Holdings (PLMR) This Year?
by Zacks Equity Research
Here is how Palomar (PLMR) and Commonwealth Bank of Australia Sponsored ADR (CMWAY) have performed compared to their sector so far this year.
Marsh & McLennan (MMC) Unit's Buyout Boosts Southeast Presence
by Zacks Equity Research
Marsh & McLennan (MMC) unit Marsh acquires FBBINSURANCE of Mississippi to further strengthen its risk management services suite and Southeast presence.
Why You Should Stay Invested in Hanover Insurance (THG) Stock
by Zacks Equity Research
Hanover Insurance (THG) stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
Fidelity National (FNF) Surges 45% in a Year: More Upside Left?
by Zacks Equity Research
Fidelity National's (FNF) market-leading position, higher direct premiums, agency premiums, strong origination demand and effective capital deployment poise it well for growth.
Here's Why Investors Should Retain CNA Financial (CNA) Stock
by Zacks Equity Research
Solid premium writing underwriting expertise, a sturdy balance sheet and capital deployment poise CNA Financial (CNA) for growth.
Zacks Industry Outlook Highlights Berkshire Hathaway, Progressive, Chubb, RLI and Palomar
by Zacks Equity Research
Berkshire Hathaway, Progressive, Chubb, RLI and Palomar are part of the Zacks Industry Outlook article.
NMI Holdings (NMIH) Gains 31% in a Year: More Room for Growth?
by Zacks Equity Research
Improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program, a solid capital position and effective capital deployment continue to drive NMI Holdings (NMIH).
Zacks Investment Ideas feature highlights: Virtu Financial, StepStone and Palomar
by Zacks Equity Research
Virtu Financial, StepStone and Palomar are part of the Zacks Investment Ideas article.
3 Unique Financial Stocks Investors Can Buy Now
by Ethan Feller
Financial stocks have been crushing it over the last year... check out these three market and sector beating stocks: Virtu Financial, StepStone Group and Palomar Holdings.
5 Property & Casualty Insurers to Watch Despite High Catastrophe Loss
by Tanuka De
Frequent catastrophes resulting in an accelerated policy renewal rate and upward pricing pressure are likely to boost the performance of Zacks Property and Casualty Insurance industry players like BRK.B, PGR, CB, RLI and PLMR.
Palomar (PLMR) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Palomar (PLMR) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
The Zacks Rank Explained: How to Find Strong Buy Finance Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
5 P&C Insurers to Buy Despite an Active Hurricane Season
by Tanuka De
Better pricing, prudent underwriting, increased exposure, favorable reserve development and a solid capital position help PGR, RLI, HCI, PLMR and PRA withstand blows from catastrophe events.
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.